Eledon Pharmaceuticals, Inc. (ELDN)
Total Valuation
ELDN has a market cap or net worth of $47.26 million. The enterprise value is $1.45 million.
| Market Cap | 47.26M |
| Enterprise Value | 1.45M |
Important Dates
The last earnings date was Thursday, May 11, 2023, after market close.
| Earnings Date | May 11, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ELDN has 22.51 million shares outstanding. The number of shares has decreased by -0.31% in one year.
| Shares Outstanding | 22.51M |
| Shares Change (YoY) | -0.31% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 10.06% |
| Owned by Institutions (%) | 48.66% |
| Float | 16.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.19 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.63 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.93, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.93 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -79.10% and return on invested capital (ROIC) is -286.30%.
| Return on Equity (ROE) | -79.10% |
| Return on Assets (ROA) | -74.20% |
| Return on Capital (ROIC) | -286.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.23M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.01% in the last 52 weeks. The beta is 2.11, so ELDN's price volatility has been higher than the market average.
| Beta (1Y) | 2.11 |
| 52-Week Price Change | -34.01% |
| 50-Day Moving Average | 2.32 |
| 200-Day Moving Average | 2.65 |
| Average Volume (30 Days) | 163,728 |
Short Selling Information
The latest short interest is 21,362, so 0.09% of the outstanding shares have been sold short.
| Short Interest | 21,362 |
| Short Previous Month | 57,200 |
| Short % of Shares Out | 0.09% |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 0.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -89.68M |
| Pretax Income | -88.87M |
| Net Income | -88.87M |
| EBITDA | -88.50M |
| EBIT | -88.87M |
| Earnings Per Share (EPS) | -$6.22 |
Balance Sheet
The company has $46.49 million in cash and $668,000 in debt, giving a net cash position of $45.82 million or $2.04 per share.
| Cash & Cash Equivalents | 46.49M |
| Total Debt | 668,000 |
| Net Cash | 45.82M |
| Net Cash Per Share | $2.04 |
| Equity / Book Value | 74.79M |
| Book Value Per Share | 3.32 |
| Working Capital | 43.43M |
Cash Flow
| Operating Cash Flow | -30.19M |
| Capital Expenditures | n/a |
| Free Cash Flow | -30.19M |
| FCF Per Share | -$2.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ELDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -188.03% |
| FCF Yield | -63.88% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.31% |
| Shareholder Yield | 0.31% |
Analyst Forecast
The average price target for ELDN is $25.50, which is 1,114.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.50 |
| Price Target Difference | 1,114.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -17.70% |
Stock Splits
The last stock split was on October 5, 2020. It was a reverse split with a ratio of 1:18.
| Last Split Date | Oct 5, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:18 |